The Biotech Story

Paula M. Rayman

Chapter Chapter Five in Beyond the Bottom Line, 2001, pp 109-134 from Palgrave Macmillan

Abstract: Abstract When the biotech industry burst on the scene in the 1970s, it was seen as a network of sexy start-up companies resting on the shaky foundation of venture capital. The firms tended to be small, with more than half employing fewer than 50 employees and 90 percent employing fewer than 500. In this “small but beautiful” environment, some of the most research-intensive work ever done by humans has been conducted. Just in the United States in one year, 1999, the biotech industry spent almost $11 billion on research and development. This money produced about 153,000 jobs in over 1,200 companies clustered in a few national regions—metropolitan Boston, Silicon Valley, Texas, and North Carolina’s Triangle area.

Keywords: Social Responsibility; Child Care; Venture Capital; Bottom Line; Stock Option (search for similar items in EconPapers)
Date: 2001
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pal:palchp:978-1-137-04513-3_5

Ordering information: This item can be ordered from
http://www.palgrave.com/9781137045133

DOI: 10.1007/978-1-137-04513-3_5

Access Statistics for this chapter

More chapters in Palgrave Macmillan Books from Palgrave Macmillan
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().